Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Resilinc’s Agentic Factory for Operational Supply Chain Resilience at Hannover Messe 2026
-
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
-
Re-Opening of Offer for Subscription to Further Applications
-
La Banque Postale announces the early redemption of its EUR 750,000,000 Perpetual Fixed Rate Resettable Additional Tier 1 Notes issued on 20 November 2019 (ISIN FR0013461795) (the “Additional Tier
-
Data on debtor composition
-
Preliminary data on early redemptions (prepayments)
-
Plaee Expands Its Focus as Prediction Markets Gain Momentum
-
Makko launches AI-powered 2D game studio with over 40,000 game assets created in Beta
-
Share buyback programme – week 16
-
Share repurchase programme: Transactions of week 16 2026
-
Diversified Energy TR-1
-
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
-
Swedish Goverment Holds Decision on Norra Karr Exploitation Concession; Directors Exercise Options Injecting New Capital; Investor Relations Engagement
-
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
-
Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional Investors
-
Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional Investors
-
Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations
-
Casino Group Communication
-
Equinor ASA: Buy-back of shares to share programmes for employees
-
Major Shareholder Announcement
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
KBC Group: Notification for bondholders of KBC IFIMA
-
Flow Traders appoints Frank Drouet as CEO Asia-Pacific to support regional expansion
-
Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026
-
TGS Webcast Details for Q1 2026 Presentation
-
Tallinna Vesi is introducing upgrades to improve the customer experience
-
Aktsiaselts Infortar own share acquisition transactions
-
Start of Day Message
-
Trifork Announces New Board Members to Advance Product-Led Growth and AI Strategy
-
RUBIS: Composition of the Supervisory Board
-
A subsidiary of EfTEN Real Estate Fund AS sold an office building at Menulio 11 in Vilnius
-
Q1 2026 Trading Update and Invitation to Earnings Call
-
TGS Announces Extension to Multi-Year Ocean Bottom Node Contract
-
Aktsiaselts Infortar to continue buy-back of up to 250,000 own shares
-
Mowi ASA (OSE:MOWI): Q1 2026 Trading update
-
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med SKAKO aktier
-
B2Gold Reports Update on Fire-Related Incident to the Crushing Circuit at the Goose Mine
-
Jacob Wheeler Wins Major League Fishing’s Bass Pro Shops REDCREST 2026 Presented by Mercury and Lowrance at Table Rock Lake
-
Douce Vallée Expands B2B Operations with Bespoke Corporate Gifting and Event Dessert Services in Hong Kong
-
Duncan Brand Announces Release of “Mind the Gap,” Addressing Gaps in Leadership Development Practices
-
SQRIL Expands to Africa with Launch of Stablecoin-to-Fiat QR Payments and Mobile Money Integration in Tanzania, Kenya, and South Africa
-
BIGC Targets Global Live Market with Its All-in-One Digital Venue, Achieving 1,028% Growth in Three Years
-
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
-
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
-
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
-
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
-
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
-
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

